NXTC - NextCure, Inc.
12.39
-0.370 -2.986%
Share volume: 80,651
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$12.76
-0.37
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-07-2024 | 03-06-2025 | 05-01-2025 | 08-07-2025 | 11-05-2025 | 03-05-2026 | |
| Assets | |||||||||
| Total Assets | 115.159 M | 102.589 M | 90.345 M | 80.860 M | 67.137 M | 47.689 M | 39.613 M | 50.183 M | |
| Current Assets | 102.552 M | 90.455 M | 78.693 M | 71.807 M | 58.897 M | 40.015 M | 32.640 M | 43.747 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 77.643 M | 65.588 M | 47.606 M | 40.894 M | 34.033 M | 30.416 M | 21.786 M | 15.836 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 18.358 M | 20.848 M | 27.702 M | 27.727 M | 21.827 M | 4.892 M | 7.324 M | 25.982 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 7.097 M | 6.699 M | 6.167 M | 5.458 M | 4.804 M | 4.171 M | 3.638 M | 3.273 M | |
| Other Assets | 5.510 M | 5.435 M | 5.485 M | 3.595 M | 3.436 M | 3.503 M | 3.335 M | 3.163 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 115.159 M | 102.589 M | 90.345 M | 80.860 M | 67.137 M | 47.689 M | 39.613 M | 50.183 M | |
| Total liabilities | 16.111 M | 17.148 M | 14.753 M | 15.388 M | 11.282 M | 16.043 M | 15.967 M | 15.240 M | |
| Total current liabilities | 9.583 M | 10.833 M | 8.672 M | 9.574 M | 5.740 M | 10.781 M | 10.995 M | 10.566 M | |
| Accounts Payable | 4.491 M | 5.075 M | 3.613 M | 5.353 M | 2.736 M | 2.544 M | 2.391 M | 2.011 M | |
| Other liabilities | 755.000 K | 725.000 K | 693.000 K | 661.000 K | 629.000 K | 596.000 K | 561.000 K | 526.000 K | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 755.000 K | 725.000 K | 693.000 K | 661.000 K | 629.000 K | 596.000 K | 561.000 K | 526.000 K | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 99.048 M | 85.441 M | 75.592 M | 65.472 M | 55.855 M | 29.646 M | 23.646 M | 34.943 M | |
| Common stock | 440.819 M | 442.520 M | 444.049 M | 445.604 M | 446.967 M | 447.573 M | 450.173 M | 470.902 M | |
| Retained earnings | -341.589 M | -356.993 M | -368.533 M | -380.136 M | -391.112 M | -417.920 M | -426.544 M | -435.980 M |